Industry Research Reports and Market Analysis at MindBranch.com

Canada In Vitro Diagnostics Investment Opportunities Analysis and Forecasts to 2012

Published By: Global Markets Direct
September 2008
R3480-6220
Online Download   $3,000.00
Global Site License   $9,000.00
Description

Canada In Vitro Diagnostics Investment Opportunities Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Canada In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the In In vitro diagnostic dvices in Canada

Scope
  • The report provides in vitro diagnostics information broken down into detailed categories and segments in Canada.
  • Total revenues, end users
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.
Reasons to buy
  • Gain a strong understanding of the in vitro diagnostics devices market in Canada.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
Table of Contents
1 Table Of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets Covered in the Report
3.1 In Vitro Diagnostics Devices
3.2 Clinical Chemistry Test Reagents
3.2.1 Laboratory Reagents
3.2.2 Clinical Chemistry Calibrators and Controls
3.2.3 Clinical Chemistry Rapid Tests
3.3 Immunochemistry Test Reagents
3.3.1 Disease Specific Markers
3.3.2 Disease Specific Test Reagents
3.3.3 Drug Related Testing Reagents
3.3.4 Hormone Related Testing Reagents
3.3.5 Immunochemistry Calibrators and Controls
3.3.6 Immunochemistry Rapid Tests
3.4 Blood Test Reagents
3.4.1 Hematology Test Reagents
3.4.2 Hemostasis Test Reagents
3.4.3 Tissue Typing Reagents
3.4.4 Monoclonal Antibodies
3.4.5 Cytokines and Immunomodulators
3.4.6 Histology and Cytology Reagents
3.5 Microbiology Test Reagents
3.5.1 Bacteriology Test Reagents
3.5.2 Microbiology Calibrators and Controls
3.5.3 Microbiology Rapid Tests
3.6 Infectious Immunology Test Reagents
3.6.1 Bacteriology
3.6.2 Virology
3.6.3 Parasitology
3.6.4 Infectious Immunology Calibrators and Controls
3.6.5 Infectious Immunology Rapid Tests
3.7 Genetic Test Reagents
3.8 Self Testing
3.9 Instruments
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.3 Healthcare Policy
4.4 Canada Healthcare Trade Statistics
5 Regulation System
5.1 Medical Equipment Approval Process
5.1.1 Classification
5.1.2 Conformity Assessment
5.1.3 License Fee
5.1.4 License Application Processing Duration
5.2 Labeling and Packaging
5.3 Post-Market Surveillance
6 Pricing and Reimbursement
7 Distribution Structure
7.1 Distribution Structure
8 Canada Medical Equipment Cross Market Comparison
9 In Vitro Diagnostics In Canada
9.1 In Vitro Diagnostics Cross Country Comparison (2000-2012)
9.2 In Vitro Diagnostics, Canada, Overall Revenues, 2000-2012
9.3 In Vitro Diagnostics, Canada, Company Share (2006-2007)
10 Blood Test Reagents In Canada
10.1 Blood Test Reagents Overall Revenue (2000-2012)
10.1.1 Haematology Test Reagents Revenue (2000-2012)
10.1.2 Hemostasis Test Reagents Revenue (2000-2012)
10.2 Blood Test Reagents Distribution Share (2006-2007)
10.3 Blood Test Reagents, Canada, Company Share (2006-2007)
11 Clinical Chemistry Test Reagents In Canada
11.1 Clinical Chemistry Test Reagents Overall Revenue (2000-2012)
11.2 Clinical Chemistry Test Reagents Distribution Share (2006-2007)
11.3 Clinical Chemistry Test Reagents, Canada, Company Share (2006-2007)
12 Genetic Test Reagents In Canada
12.1 Genetic Test Reagents Overall Revenue (2000-2012)
12.2 Genetic Test Reagents Distribution Share (2006-2007)
12.3 Genetic Test Reagents, Canada, Company Share (2006-2007)
13 Immunochemistry Test Reagents In Canada
13.1 Immunochemistry Test Reagents Overall Revenue (2000-2012)
13.1.1 Disease Specific Markers Revenue (2000-2012)
13.1.2 Disease Specific Test Reagents Revenue (2000-2012)
13.1.3 Drug Related Testing Reagents Revenue (2000-2012)
13.1.4 Hormone Related Testing Reagents Revenue (2000-2012)
13.2 Immunochemistry Test Reagents Distribution Share (2006-2007)
13.3 Immunochemistry Test Reagents, Canada, Company Share (2006-2007)
14 Infectious Immunology Test Reagents In Canada
14.1 Infectious Immunology Test Reagents Overall Revenue (2000-2012)
14.1.1 Virology Revenue (2000-2012)
14.2 Infectious Immunology Test Reagents Distribution Share (2006-2007)
14.3 Infectious Immunology Test Reagents, Canada, Company Share (2006-2007)
15 Instruments In Canada
15.1 Instruments Overall Revenue (2000-2012)
15.2 Instruments Distribution Share (2006-2007)
15.3 Instruments, Canada, Company Share (2006-2007)
16 Microbiology Test Reagents In Canada
16.1 Microbiology Test Reagents Overall Revenue (2000-2012)
16.1.1 Bacteriology Test Reagents Revenue (2000-2012)
16.2 Microbiology Test Reagents Distribution Share (2006-2007)
16.3 Microbiology Test Reagents, Canada, Company Share (2006-2007)
17 Self Testing In Canada
17.1 Self Testing Overall Revenue (2000-2012)
17.2 Self Testing Distribution Share (2006-2007)
17.3 Self Testing, Canada, Company Share (2006-2007)
18 F. Hoffmann-La Roche Ltd. Company Profile
18.1 Company Overview
18.2 Value Chain Analysis
18.2.1 Manufacturing
18.2.2 Product Development
18.2.3 Sales and Marketing
19 Beckman Coulter, Inc. Company Profile
19.1 Company Overview
19.2 Value Chain Analysis
19.2.1 Manufacturing
19.2.2 Product Development
19.2.3 Sales and Marketing
19.3 Beckman Coulter, Inc. Pipeline Products
19.3.1 Beckman Coulter, Inc. Pipeline Products by Equipment Type
19.3.2 Beckman Coulter, Inc. Pipeline Products by Development Stage
19.3.3 Beckman Coulter, Inc. Pipeline Products by Therapy Area
19.3.4 Beckman Coulter, Inc. Pipeline Products by News Summary
20 Dade Behring Holdings, Inc. Company Profile
20.1 Company Overview
20.2 Dade Behring Holdings, Inc. Pipeline Products
20.2.1 Dade Behring Holdings, Inc. Pipeline Products by Equipment Type
20.2.2 Dade Behring Holdings, Inc. Pipeline Products by Development Stage
20.2.3 Dade Behring Holdings, Inc. Pipeline Products by Therapy Area
20.2.4 Dade Behring Holdings, Inc. Pipeline Products by News Summary
21 Abbott Laboratories Company Profile
21.1 Company Overview
21.2 Value Chain Analysis
21.2.1 Manufacturing
21.2.2 Product Development
21.2.3 Sales and Marketing
21.3 Abbott Laboratories Pipeline Products
21.3.1 Abbott Laboratories Pipeline Products by Equipment Type
21.3.2 Abbott Laboratories Pipeline Products by Development Stage
21.3.3 Abbott Laboratories Pipeline Products by Therapy Area
21.3.4 Abbott Laboratories Pipeline Products by Clinical Trials
21.3.5 Abbott Laboratories Pipeline Products by News Summary
22 Siemens Medical Solutions Company Profile
22.1 Company Overview
22.2 Value Chain Analysis
22.2.1 Manufacturing
22.2.2 Product Development
22.2.3 Sales and Marketing
22.3 Siemens Medical Solutions Pipeline Products
22.3.1 Siemens Medical Solutions Pipeline Products by Equipment Type
22.3.2 Siemens Medical Solutions Pipeline Products by Development Stage
22.3.3 Siemens Medical Solutions Pipeline Products by Therapy Area
22.3.4 Siemens Medical Solutions Pipeline Products by News Summary
23 bioMerieux S.A. Company Profile
23.1 Company Overview
23.2 Value Chain Analysis
23.2.1 Manufacturing
23.2.2 Product Development
23.2.3 Sales and Marketing
24 Affinity Biologicals Incorporated Company Profile
24.1 Company Overview
25 Biocore Systems Inc. Company Profile
25.1 Company Overview
26 bioLytical Laboratories Inc. Company Profile
26.1 Company Overview
26.2 bioLytical Laboratories Inc. Pipeline Products
26.2.1 bioLytical Laboratories Inc. Pipeline Products by Equipment Type
26.2.2 bioLytical Laboratories Inc. Pipeline Products by Development Stage
26.2.3 bioLytical Laboratories Inc. Pipeline Products By Therapy Area
26.2.4 bioLytical Laboratories Inc. Pipeline Products By Clinical Trials
26.2.5 bioLytical Laboratories Inc. Pipeline Products By News Summary
27 Biomedica Diagnostics Inc. Company Profile
27.1 Company Overview
28 Cedarlane Laboratories Limited Company Profile
28.1 Company Overview
29 Diagnostics Chemicals Limited Company Profile
29.1 Company Overview
30 DRAXIMAGE Company Profile
30.1 Company Overview
31 Medicorp Inc. Company Profile
31.1 Company Overview
32 Medmira Inc. Company Profile
32.1 Company Overview
33 Financial Deals Landscape
33.1 Acquisition
33.1.1 Roche To Acquire ARIUS Research
33.2 Venture Financing
33.2.1 Adnavance Technologies Secures $5.47 Million In Series B Financing
34 Recent Developments
34.1 Strategy and Business Planning
34.1.1 Mar 04, 2008: Biotage And McMaster Sign Two Year Extension To Molecular Imaging Development Agreement
35 APPENDIX
35.1 Global Markets Direct Research Methodology
35.2 Coverage
35.3 Secondary Research
35.4 Primary Research
35.5 Models
35.6 Forecasts
35.7 Expert Panels
35.8 Currency Conversion
35.9 Contact Us
35.10 Disclaimer
1.1 List of Tables
Table 1: Number of Physicians by Province in Canada, 2001 and 2005
Table 2: Hospital Wards by Specialty in Canada, 2003-2007
Table 3: Doctors by Specialty in Canada, 2003-2007
Table 4: Canada Healthcare Trade Statistics, 2001-2006
Table 5: Medical Equipment Classification in Canada, 2007
Table 6: Medical Equipment Licensing Fee in Canada, 2007
Table 7: Medical Equipment License Processing Duration in Canada, 2007
Table 8: Canada, Medical Equipment Market Comparison
Table 9: In Vitro Diagnostics Cross Country Comparison (2000-2012)
Table 10: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), 2000-2012
Table 11: In Vitro Diagnostics Market, Canada, Portfolio Analysis
Table 12: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), Historic, 2000-2007
Table 13: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
Table 14: In Vitro Diagnostics, Canada, Company Share by Revenue ($ mn), 2006-2007
Table 15: Blood Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
Table 16: Blood Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
Table 17: Haematology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
Table 18: Haematology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
Table 19: Hemostasis Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
Table 20: Hemostasis Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
Table 21: Blood Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007
Table 22: Blood Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007
Table 23: Clinical Chemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
Table 24: Clinical Chemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
Table 25: Clinical Chemistry Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007
Table 26: Clinical Chemistry Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007
Table 27: Genetic Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
Table 28: Genetic Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
Table 29: Genetic Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007
Table 30: Genetic Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007
Table 31: Immunochemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
Table 32: Immunochemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
Table 33: Disease Specific Markers, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
Table 34: Disease Specific Markers, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
Table 35: Disease Specific Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
Table 36: Disease Specific Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
Table 37: Drug Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
Table 38: Drug Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
Table 39: Hormone Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
Table 40: Hormone Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
Table 41: Immunochemistry Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007
Table 42: Immunochemistry Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007
Table 43: Infectious Immunology Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
Table 44: Infectious Immunology Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
Table 45: Virology, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
Table 46: Virology, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
Table 47: Infectious Immunology Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007
Table 48: Infectious Immunology Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007
Table 49: Instruments, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
Table 50: Instruments, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
Table 51: Instruments, Canada, Distribution Share by Revenue ($ mn), 2006-2007
Table 52: Instruments, Canada, Company Share by Revenue ($ mn), 2006-2007
Table 53: Microbiology Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
Table 54: Microbiology Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
Table 55: Bacteriology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
Table 56: Bacteriology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
Table 57: Microbiology Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007
Table 58: Microbiology Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007
Table 59: Self Testing, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
Table 60: Self Testing, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
Table 61: Self Testing, Canada, Distribution Share by Revenue ($ mn), 2006-2007
Table 62: Self Testing, Canada, Company Share by Revenue ($ mn), 2006-2007
Table 63: Beckman Coulter, Inc. Pipeline Products by Equipment Type
Table 64: Beckman Coulter, Inc. Pipeline Products By Development Stage
Table 65: Beckman Coulter, Inc. Pipeline Products By Therapy Area
Table 66: Beckman Coulter, Inc. Pipeline Products By News Summaries
Table 67: Dade Behring Holdings, Inc. Pipeline Products by Equipment Type
Table 68: Dade Behring Holdings, Inc. Pipeline Products By Development Stage
Table 69: Dade Behring Holdings, Inc. Pipeline Products By Therapy Area
Table 70: Dade Behring Holdings, Inc. Pipeline Products By News Summaries
Table 71: Abbott Laboratories Pipeline Products by Equipment Type
Table 72: Abbott Laboratories Pipeline Products By Development Stage
Table 73: Abbott Laboratories Pipeline Products By Therapy Area
Table 74: Abbott Laboratories Pipeline Products By Clinical Trials
Table 75: Abbott Laboratories Pipeline Products By News Summaries
Table 76: Siemens Medical Solutions Pipeline Products by Equipment Type
Table 77: Siemens Medical Solutions Pipeline Products By Development Stage
Table 78: Siemens Medical Solutions Pipeline Products By Therapy Area
Table 79: Siemens Medical Solutions Pipeline Products By News Summaries
Table 80: bioLytical Laboratories Inc. Pipeline Products by Equipment Type
Table 81: bioLytical Laboratories Inc. Pipeline Products By Development Stage
Table 82: bioLytical Laboratories Inc. Pipeline Products By Therapy Area
Table 83: bioLytical Laboratories Inc. Pipeline Products By Clinical Trials
Table 84: bioLytical Laboratories Inc. Pipeline Products By News Summaries
Table 85: Currency Conversion from USD to Local Currency at 2007 Constant Rate
1.2 List of Figures
Figure 1: Healthcare Financing in Canada, 2004
Figure 2: Healthcare Expenditure in Canada, 2000 - 2006
Figure 3: Canada, Medical Equipment Market Comparison,2007
Figure 4: In Vitro Diagnostics Cross Country Comparison (2000-2012)
Figure 5: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), 2000-2012
Figure 6: In Vitro Diagnostics Market, Canada, Portfolio Analysis
Figure 7: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), Historic, 2000-2007
Figure 8: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 9: In Vitro Diagnostics, Canada, Company Share (%), 2007
Figure 10: Blood Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
Figure 11: Blood Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
Figure 12: Haematology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
Figure 13: Haematology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
Figure 14: Hemostasis Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
Figure 15: Hemostasis Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
Figure 16: Blood Test Reagents, Canada, Company Share (%), 2007
Figure 17: Clinical Chemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
Figure 18: Clinical Chemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
Figure 19: Clinical Chemistry Test Reagents, Canada, Company Share (%), 2007
Figure 20: Genetic Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
Figure 21: Genetic Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
Figure 22: Genetic Test Reagents, Canada, Company Share (%), 2007
Figure 23: Immunochemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
Figure 24: Immunochemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
Figure 25: Disease Specific Markers, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
Figure 26: Disease Specific Markers, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
Figure 27: Disease Specific Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
Figure 28: Disease Specific Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
Figure 29: Drug Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
Figure 30: Drug Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
Figure 31: Hormone Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
Figure 32: Immunochemistry Test Reagents, Canada, Company Share (%), 2007
Figure 33: Infectious Immunology Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
Figure 34: Infectious Immunology Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
Figure 35: Virology, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
Figure 36: Virology, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
Figure 37: Infectious Immunology Test Reagents, Canada, Company Share (%), 2007
Figure 38: Instruments, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
Figure 39: Instruments, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
Figure 40: Instruments, Canada, Company Share (%), 2007
Figure 41: Microbiology Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
Figure 42: Bacteriology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007
Figure 43: Bacteriology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012
Figure 44: Microbiology Test Reagents, Canada, Company Share (%), 2007
Figure 45: Self Testing, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007
Figure 46: Self Testing, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012
Figure 47: Self Testing, Canada, Company Share (%), 2007
Figure 48: F. Hoffmann-La Roche Ltd Value Chain Analysis
Figure 49: Beckman Coulter, Inc. Value Chain Analysis
Figure 50: Abbott Laboratories Value Chain Analysis
Figure 51: Siemens Medical Solutions Value Chain Analysis
Figure 52: Biomerieux Sa Value Chain Analysis
Figure 53: Global Markets Direct Methodology
Order Form
       * Please reference product number R3480-6220 when ordering or inquiring.
PUBLICATION:   Canada In Vitro Diagnostics Investment Opportunities Analysis and Forecasts to 2012
QTY. FORMAT PRICE TOTAL
  Online Download$3,000.00   
  Global Site License$9,000.00   
  SUBTOTAL   
SHIPPING CHARGES
 (U.S. $25, Canada $35, Int'l $65) 		 
TOTAL  

CONTACT INFORMATION
PAYMENT INFORMATION
Name ____________________________________________ MasterCard VISA AmEx Discover

__________________________________
Account number                 Exp. date

__________________________________
Signature

__________________________________
Email

Please invoice
      (shipment on receipt of payment)
Payment enclosed
*CHECKS / WIRE TRANSFERS:
Checks must be paid in U.S. funds.
Please call for details.
Company ____________________________________________
Job Title ____________________________________________
Address ____________________________________________
City ____________________________________________
Company ____________________________________________
State ______________________________   Zip__________
Country ____________________________________________
Phone ____________________________________________
MindBranch, Inc.,     131 Ashland St., Suite 200 North Adams, MA  01247       tel: 800-774-4410     fax: +1-413-664-9791     www.mindbranch.com